Healthcare

Pharmaceuticals Stock Market Investments Pharmaceuticals Medicare Health Insurance Market Analysis Earnings Reports Drug Development Investment

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Novo Nordisk and Cigna introduce temporary discounts and copay caps as compounded semaglutide distribution ceases under new FDA regulations.

Hinge Health Begins NYSE Trading After $273 Million IPO

Sanofi to Acquire Vigil Neuroscience in $600M Deal to Advance Alzheimer’s Research

UnitedHealth Faces Leadership Shakeup and DOJ Probes Amid $280 Billion Stock Wipeout

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

Novo Nordisk CEO Steps Down Following Share Price Collapse

Rite Aid Finalizes Sale of Pharmacy Assets to CVS, Walgreens, and Grocers

UnitedHealth CEO Resigns as Company Withdraws 2025 Financial Outlook

Hims & Hers Reaffirms Growth Targets After Record Q1 Performance and Convertible Note Offering

Newsom Pushes State Regulation of PBMs and CalRx Expansion in 2025 Budget Plan

UnitedHealth Faces Investor Lawsuit Over CEO’s Killing and Profit Impact

Charles River Labs Reshapes Board and Launches Strategic Review Following Elliott Deal

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

Hims & Hers Reports Record Q1 Results While Stock Dips on Cautious Q2 Guidance

CVS Health Beats Q1 Expectations and Raises 2025 Earnings Guidance

Moderna Reports Narrower Q1 Loss, Updates Cost-Cutting and Regulatory Timelines

Eli Lilly Reports Record Q1 Revenue but Faces Profit Pressure and Competitive Challenges

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Merck KGaA Confirms $3.9 Billion Acquisition of SpringWorks Therapeutics